AI-Powered. Expert-Tailored.
Clarity for Complex IP, R&D, and Scientific Decisions.
We help leaders move critical decisions forward through structured analysis, expert insight, and technology-supported delivery, providing evidence and direction with speed and confidence.
50+ Global Enterprises Count on Evalueserve IP and R&D











Seminar in Seoul: From Patents to Profits: Real Cases of IP Monetization Success
Where We Focus
Drive Growth with Strategic IP and R&D Synergy.
From strategy to execution, delivering services that accelerate innovation and market success.
Strengthen Your
IP Strategy & Portfolio Positioning
Assess portfolio strength, competitive positioning to maximize IP value and strategic advantage.
Accelerate Your
R&D & Innovation
Pipeline
Evidence-based insights to guide R&D pipelines, ecosystem, and technology investments.
Navigate Complex
Scientific & Regulatory Pathways
Structured evaluation of evidence, safety, and regulatory strategy.
Optimize Your Processes With
AI-Assisted Workflows
Streamlined patent searches, competitive insights, and innovation scouting powered by AI.
Awards & Recognition
Recognized for "strength in domain-specific AI" *
* Chartis






eBook
How Can You Mitigate Risks in Medical Device Development
Learn how to navigate safety challenges in medical device development with trusted experts.
Success Story
Driving Revenue with Precision: AI-Assisted Patent Licensing Workflow
Discover how a global technology leader streamlined patent licensing with Evalueserve.
Our Clients
Success Stories.
Strategic Patentability Enhancement for a Manufacturing Leader
Sustainable Innovation in Polymer Production
Enhancing Chemical Safety and Compliance Through Strategic Collaboration
- SWIPE
Related Resources
Latest Insights from the IP and R&D World.

Network APIs: Why Telcos Are Shifting from Connectivity to Platform Economics
Network APIs are reshaping telecom into platform-driven ecosystems, enabling seamless access to connectivity, identity, and performance capabilities across operators and markets.

Patent Expiry Is Not Fixed: How USPTO Extensions Reshape Revenue, Risk, and Market Entry
Patent Expiry is no longer a fixed date. Discover how USPTO patent term extensions reshape pharma strategy, market access, and competitive risk.

The Hidden Risk of AI Adoption: Context Blindness
The risk of AI adoption increases when context is ignored. Explore how context blindness impacts strategy, patent licensing decisions, and enterprise value creation.

What AI Actually Means in Toxicology Workflows?
What AI Actually Means for toxicology workflows: practical use cases, regulatory expectations, and the limits of automation in safety assessment.
- SWIPE
About Us
Are You Driven to Deliver?
At Evalueserve, we're committed to driving world-moving outcomes. We're building a high-performing, outcome driven culture that's made stronger by its diverse perspectives and global footprint.